Skip to main content

Advertisement

SpringerLink
Log in

Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, Shenone E, Pascale GD, Molinari MP, Cauda R, Viscoli C, Tumbarello M (2012) Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 18:862–869

    Article  CAS  PubMed  Google Scholar 

  2. Moore CK, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ (2012) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 54:51–58

    Article  CAS  PubMed  Google Scholar 

  3. Bassetti M, Nicco E, Ginocchio F, Ansaldi F, de Florentiis D, Viscoli C (2010) High-dose daptomycin in documented Staphylococcus aureus infections. Int J Antimicrob Agents 36:459–461

    Article  CAS  PubMed  Google Scholar 

  4. Bassetti M, Villa G, Ansaldi F, De Florentiis D, Tascini C, Cojutti P, Righi E, Sartor A, Crapis M, De Rosa FG, Pea F, Menichetti F (2015) Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. Intensive Care Med 41:366–368

    Article  PubMed  Google Scholar 

  5. Lodise TP Jr, McKinnon PS, Levine DP, Rybak MJ (2007) Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 51:3731–3733

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work was carried out as part of the regular work of the hospital and university departments.

Author information

Authors and Affiliations

  1. Infectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy

    Matteo Bassetti, Elda Righi & Alessia Carnelutti

  2. Department of Health Sciences, IRCCS San Martino IST, University of Genoa, Genoa, Italy

    Filippo Ansaldi & Daniela De Florentiis

  3. Institute of Clinical Pharmacology, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine, Italy

    Federico Pea

  4. Microbiology Unit, Santa Maria Misericordia University Hospital, Udine, Italy

    Assunta Sartor & Claudio Scarparo

  5. Clinica Malattie Infettive, Azienda Ospedaliera Universitaria Santa Maria della Misericordia, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy

    Matteo Bassetti

Authors
  1. Matteo Bassetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Filippo Ansaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela De Florentiis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elda Righi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Federico Pea
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Assunta Sartor
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Claudio Scarparo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alessia Carnelutti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matteo Bassetti.

Ethics declarations

Conflicts of interest

MB and FP received funding for travel or speaker honoraria from Novartis and MSD. The work was carried out as part of the regular work of the hospital and university departments. The other authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bassetti, M., Ansaldi, F., De Florentiis, D. et al. Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience. Intensive Care Med 41, 2026–2028 (2015). https://doi.org/10.1007/s00134-015-4021-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-015-4021-9

Keywords

Search

Navigation